Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NRx Pharmaceuticals Inc.

    NASDAQ: NRXP · Real-Time Price · USD
    3.49
    0.05 (1.45%)
    At close: Jun 16, 2025, 3:59 PM
    3.43
    -1.69%
    After-hours: Jun 16, 2025, 07:42 PM EDT

    NRx Pharmaceuticals Statistics

    Share Statistics

    NRx Pharmaceuticals has 17.29M shares outstanding. The number of shares has increased by 58.08% in one year.

    Shares Outstanding

    n/a
    		 17.29M

    Shares Change (YoY)

    n/a
    		 58.08%

    Shares Change (QoQ)

    n/a
    		 39.87%

    Owned by Institutions (%)

    n/a
    		 0.03%

    Shares Floating

    n/a
    		 14.34M

    Failed to Deliver (FTD) Shares

    n/a
    		 89,336

    FTD / Avg. Volume

    n/a
    		 34.92%

    Short Selling Information

    The latest short interest is 1.11M, so 6.44% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.11M

    Short % of Shares Out

    n/a
    		 6.44%

    Short % of Float

    n/a
    		 7.18%

    Short Ratio (days to cover)

    n/a
    		 2.9

    Valuation Ratios

    The PE ratio is -0.92 and the forward PE ratio is 4.93. NRx Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -0.92

    Forward PE

    n/a
    		 4.93

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -1

    P/FCF Ratio

    n/a
    		 -2.18

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for NRx Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.15, with a Debt / Equity ratio of -0.28.

    Current Ratio

    n/a
    		 0.15

    Quick Ratio

    n/a
    		 0.15

    Debt / Equity

    n/a
    		 -0.28

    Debt / EBITDA

    n/a
    		 -0.36

    Debt / FCF

    n/a
    		 -0.62

    Interest Coverage

    n/a
    		 -80.44

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-12,563,000

    Employee Count

    n/a
    		 2

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 13.68% in the last 52 weeks. The beta is 1.55, so NRx Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.55

    52-Week Price Change

    n/a
    		 13.68%

    50-Day Moving Average

    n/a
    		 2.4

    200-Day Moving Average

    n/a
    		 2.1

    Relative Strength Index (RSI)

    n/a
    		 73.35

    Average Volume (20 Days)

    n/a
    		 255,850

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -18.5M

    Net Income

    n/a
    		 -25.13M

    EBITDA

    n/a
    		 -18.5M

    EBIT

    n/a
    		 -24.9M

    Earnings Per Share (EPS)

    n/a
    		 -2.39
    Full Income Statement

    Balance Sheet

    The company has 1.44M in cash and 6.58M in debt, giving a net cash position of -5.13M.

    Cash & Cash Equivalents

    n/a
    		 1.44M

    Total Debt

    n/a
    		 6.58M

    Net Cash

    n/a
    		 -5.13M

    Retained Earnings

    n/a
    		 -278.27M

    Total Assets

    n/a
    		 7.59M

    Working Capital

    n/a
    		 -25.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.64M and capital expenditures 0, giving a free cash flow of -10.64M.

    Operating Cash Flow

    n/a
    		 -10.64M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -10.64M

    FCF Per Share

    n/a
    		 -1.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NRXP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NRXP is $31, which is 788.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $31

    Price Target Difference

    n/a
    		 788.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 2, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Apr 2, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -66.01

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist